Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerome Breen

Showing results (121-130 of 379) with videos related to

Pageof 38
Sort By:
Schizophrenia Research|July 3, 2003
Association of APOE gene with schizophrenia in Chinese: a possible risk factor in times of malnutritionWanqing Liu, Gerome Breen, Jiangang Zhang, et al.
Plos Genetics|March 3, 2022
Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19Alish B Palmos, Vincent Millischer, David K Menon, et al.
Translational Psychiatry|May 14, 2020
Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?Chandni Hindocha, Diego Quattrone, Tom P Freeman, et al.
BMC Psychiatry|June 10, 2014
Predicting outcome following psychological therapy in IAPT (PROMPT): a naturalistic project protocolNina Grant, Matthew Hotopf, Gerome Breen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 1, 2011
Differential activity by polymorphic variants of a remote enhancer that supports galanin expression in the hypothalamus and amygdala: implications for obesity, depression and alcoholismScott Davidson, Marissa Lear, Lynne Shanley, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 20, 2012
Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'Annamaria Cattaneo, Massimo Gennarelli, Rudolf Uher, et al.
The International Journal of Eating Disorders|June 17, 2025
Beyond the Diagnostic Checklist: A Large-Scale Analysis of Under-Recognized Weight Loss Behaviors in Individuals With Eating DisordersSaakshi Kakar, Una Foye, Helena L Davies, et al.
Behaviour Research and Therapy|September 7, 2019
Genetic influences on treatment-seeking for common mental health problems in the UK biobankChristopher Rayner, Jonathan R I Coleman, Kirstin L Purves, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 18, 2021
Self-reported medication use as an alternate phenotyping method for anxiety and depression in the UK BiobankMegan Skelton, Christopher Rayner, Kirstin L Purves, et al.
Plos One|January 10, 2013
Linkage replication for chromosomal region 13q32 in schizophrenia: evidence from a Brazilian pilot study on early onset schizophrenia familiesAry Gadelha, Vanessa Kiyomi Ota, Jose Paya Cano, et al.
Pageof 38

Showing results (121-130 of 379) with videos related to

Sort By:
Pageof 38
Schizophrenia Research|July 3, 2003
Association of APOE gene with schizophrenia in Chinese: a possible risk factor in times of malnutritionWanqing Liu, Gerome Breen, Jiangang Zhang, et al.
Plos Genetics|March 3, 2022
Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19Alish B Palmos, Vincent Millischer, David K Menon, et al.
Translational Psychiatry|May 14, 2020
Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?Chandni Hindocha, Diego Quattrone, Tom P Freeman, et al.
BMC Psychiatry|June 10, 2014
Predicting outcome following psychological therapy in IAPT (PROMPT): a naturalistic project protocolNina Grant, Matthew Hotopf, Gerome Breen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 1, 2011
Differential activity by polymorphic variants of a remote enhancer that supports galanin expression in the hypothalamus and amygdala: implications for obesity, depression and alcoholismScott Davidson, Marissa Lear, Lynne Shanley, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 20, 2012
Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'Annamaria Cattaneo, Massimo Gennarelli, Rudolf Uher, et al.
The International Journal of Eating Disorders|June 17, 2025
Beyond the Diagnostic Checklist: A Large-Scale Analysis of Under-Recognized Weight Loss Behaviors in Individuals With Eating DisordersSaakshi Kakar, Una Foye, Helena L Davies, et al.
Behaviour Research and Therapy|September 7, 2019
Genetic influences on treatment-seeking for common mental health problems in the UK biobankChristopher Rayner, Jonathan R I Coleman, Kirstin L Purves, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 18, 2021
Self-reported medication use as an alternate phenotyping method for anxiety and depression in the UK BiobankMegan Skelton, Christopher Rayner, Kirstin L Purves, et al.
Plos One|January 10, 2013
Linkage replication for chromosomal region 13q32 in schizophrenia: evidence from a Brazilian pilot study on early onset schizophrenia familiesAry Gadelha, Vanessa Kiyomi Ota, Jose Paya Cano, et al.
Pageof 38